Home » Topics » BioWorld

BioWorld
RSS

FRENCH-RUSSIAN ANTISENSE COLLABORATION

April 30, 1992

ABS LICENSES BREAST CANCER SCREEN

April 30, 1992

GTII LICENSES LDL GENE

April 30, 1992

MOLECULAR BIO CLAIMS ANTISENSE POSITION

April 30, 1992

IMMUCOR BUYING BACK SHARES

April 30, 1992

GENZYME SPINOFF RAISES $73.5M

April 30, 1992

CELLPRO SUES OVER STEM CELL TECHNOLOGY

April 30, 1992

GENELABS PARTNERSHIP FOR DNA-BINDING DRUGS

April 29, 1992

INVESTORS CATCH UP TO SPINOFF

April 29, 1992

BIOTECH-DEVICE COLLABORATION ON PAIN

April 29, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...